
Levocetirizine (5mg) + Ambroxol (75mg) + Montelukast (10mg)
Active composition
+2 more active ingredients
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Ambroxol stimulates the secretion of mucus and reduces its viscosity, facilitating easier expectoration.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medical applications
Montespace-AL Tablet SR is a once-daily, slow-release formulation designed to provide sustained relief from respiratory and allergic symptoms. This triple-ingredient combination contains Ambroxol 75mg, a mucolytic agent that helps to break down and clear mucus from the respiratory tract, Levocetirizine 5mg, a potent antihistamine that effectively alleviates pruritus, erythema, and edema associated with allergic reactions, and Montelukast 10mg, a leukotriene receptor antagonist that inhibits the production of pro-inflammatory mediators and reduces bronchospasm. The slow-release technology ensures a consistent and prolonged release of the active ingredients over 24 hours, providing a steady and effective treatment throughout the day. Montespace-AL Tablet SR is indicated for the treatment of chronic obstructive pulmonary disease (COPD), allergic rhinitis, and seasonal allergic rhinitis. It is also useful in the management of asthma, bronchitis, and bronchiectasis. The formulation is suitable for patients with mild to moderate respiratory and allergic symptoms, and is particularly beneficial for those who require long-term treatment.
How to use Montespace-AL Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Montespace-AL Tablet SR may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Montespace-AL Tablet SR. Please consult your doctor.
High Risk
Montespace-AL Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Montespace-AL Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Montespace-AL Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Montespace-AL Tablet SR may be needed. Please consult your doctor.
Regular Checkup
Montespace-AL Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Montespace-AL Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Montespace-AL Tablet SR may be needed. Please consult your doctor. Use of Montespace-AL Tablet SR is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Montespace-AL Tablet SR

Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Ambroxol stimulates the secretion of mucus and reduces its viscosity, facilitating easier expectoration.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medical applications
Montespace-AL Tablet SR is a once-daily, slow-release formulation designed to provide sustained relief from respiratory and allergic symptoms. This triple-ingredient combination contains Ambroxol 75mg, a mucolytic agent that helps to break down and clear mucus from the respiratory tract, Levocetirizine 5mg, a potent antihistamine that effectively alleviates pruritus, erythema, and edema associated with allergic reactions, and Montelukast 10mg, a leukotriene receptor antagonist that inhibits the production of pro-inflammatory mediators and reduces bronchospasm. The slow-release technology ensures a consistent and prolonged release of the active ingredients over 24 hours, providing a steady and effective treatment throughout the day. Montespace-AL Tablet SR is indicated for the treatment of chronic obstructive pulmonary disease (COPD), allergic rhinitis, and seasonal allergic rhinitis. It is also useful in the management of asthma, bronchitis, and bronchiectasis. The formulation is suitable for patients with mild to moderate respiratory and allergic symptoms, and is particularly beneficial for those who require long-term treatment.
How to use Montespace-AL Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Montespace-AL Tablet SR may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Montespace-AL Tablet SR. Please consult your doctor.
High Risk
Montespace-AL Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Montespace-AL Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Montespace-AL Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Montespace-AL Tablet SR may be needed. Please consult your doctor.
Regular Checkup
Montespace-AL Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Montespace-AL Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Montespace-AL Tablet SR may be needed. Please consult your doctor. Use of Montespace-AL Tablet SR is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Montespace-AL Tablet SR















